Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Cholangiocarcinoma 2 Bile Duct Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Lung Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1

Interventions

Cisplatin 38 Carboplatin 28 Gemcitabine 23 Docetaxel 20 Radiotherapy 18 Etoposide 15 Paclitaxel 13 Erlotinib Hydrochloride 13 Vinorelbine 11 Drug Therapy 11 pembrolizumab 9 aumolertinib 9 apatinib 9 Pemetrexed 9 Gefitinib 9 osimertinib 7 endostar protein 7 Thoracic Surgery, Video-Assisted 7 Blood Specimen Collection 7 camrelizumab 6 anlotinib 6 Vinblastine 6 Surgical Procedures, Operative 6 sintilimab 5 Radiosurgery 5 Fluorodeoxyglucose F18 5 Cyclophosphamide 5 Bevacizumab 5 durvalumab 4 Mitomycin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lung Neoplasms × 1-phenyl-3,3-dimethyltriazene × Clear all

NCT01842555 2018-08-24

PDT Registry

Main Line Health

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡